Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Cost-Effectiveness Analysis. [electronic resource]
Producer: 20190729Description: e004171 p. digitalISSN:- 1941-7705
- Aged
- Atherosclerosis -- blood
- Clinical Decision-Making
- Cost-Benefit Analysis
- Decision Support Techniques
- Decision Trees
- Drug Costs
- Dyslipidemias -- blood
- Female
- Gene Expression Profiling -- economics
- Genetic Association Studies
- Genetic Markers
- Genetic Predisposition to Disease
- Health Status
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- economics
- Lipids -- blood
- Male
- Markov Chains
- Middle Aged
- Models, Economic
- Phenotype
- Polymorphism, Single Nucleotide
- Predictive Value of Tests
- Primary Prevention -- economics
- Quality-Adjusted Life Years
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.